Trials / Sponsors / Elusys Therapeutics
Elusys Therapeutics
Academic / Other · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis Infection, Bacterial, Anthrax | Phase 4 | 2023-12-01 |
| Completed | Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunt Inhalational Anthrax | Phase 1 | 2013-10-29 |
| Completed | Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers Inhalational Anthrax | Phase 1 | 2013-07-26 |
| Completed | Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers Inhalational Anthrax | Phase 1 | 2013-07-23 |
| Completed | Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers Inhalational Anthrax | Phase 1 | 2013-07-09 |
| Completed | Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers Anthrax | Phase 1 | 2011-10-01 |
| Completed | Intravenous Dose-Escalation Study With ETI-204 in Adult Volunteers Healthy Volunteers | Phase 1 | 2009-02-01 |